Improved process for the manufacture of mirtazapine

Details for Australian Patent Application No. 2005263761 (hide)

Owner Medichem, S.A.

Inventors Arnalot Aguilar, Carmen

Agent Davies Collison Cave

Pub. Number AU-A-2005263761

PCT Pub. Number WO2006/008302

Priority 200401804 22.07.04 ES

Filing date 19 July 2005

Wipo publication date 26 January 2006

International Classifications

C07D 471/00 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/008302 Priority application(s): WO2006/008302

17 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005263762-Octahydropyrrolo[2, 3, c]pyridine derivatives and pharmaceutical use thereof

2005263756-Push to watch network element and software architecture